These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19142421)

  • 21. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
    Kluge M; Dietzel J
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871
    [No Abstract]   [Full Text] [Related]  

  • 22. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].
    Carey PD; Vythilingum B; Seedat S; Muller JE; van Ameringen M; Stein DJ
    BMC Psychiatry; 2005 Jan; 5():5. PubMed ID: 15667657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing agitation associated with traumatic brain injury: behavioral versus pharmacologic interventions?
    Flanagan SR; Elovic EP; Sandel E
    PM R; 2009 Jan; 1(1):76-80. PubMed ID: 19627876
    [No Abstract]   [Full Text] [Related]  

  • 24. Naltrexone for the treatment of trichotillomania: a case report.
    Carrion VG
    J Clin Psychopharmacol; 1995 Dec; 15(6):444-5. PubMed ID: 8748437
    [No Abstract]   [Full Text] [Related]  

  • 25. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
    Kordon A; Wahl K; Koch N; Zurowski B; Anlauf M; Vielhaber K; Kahl KG; Broocks A; Voderholzer U; Hohagen F
    J Clin Psychopharmacol; 2008 Oct; 28(5):550-4. PubMed ID: 18794652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New-onset trichotillomania in a 50-year-old patient.
    Arunkumar V; Mahadevan J; Kattimani S; Gupta D
    Aust N Z J Psychiatry; 2015 Jul; 49(7):665. PubMed ID: 25834135
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonergic drugs in trichotillomania: treatment results in 12 patients.
    Iancu I; Weizman A; Kindler S; Sasson Y; Zohar J
    J Nerv Ment Dis; 1996 Oct; 184(10):641-4. PubMed ID: 8917164
    [No Abstract]   [Full Text] [Related]  

  • 28. New behavioral approach to trichotillomania.
    Salama SA; Salama AA
    Am J Psychiatry; 1999 Sep; 156(9):1469-70. PubMed ID: 10484966
    [No Abstract]   [Full Text] [Related]  

  • 29. Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder: a randomized, placebo-controlled study.
    Altamura AC; Serati M; Buoli M; Dell'Osso B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):201-5. PubMed ID: 21403524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine resolves psychotic depression in an adolescent boy.
    Padla D
    J Child Adolesc Psychopharmacol; 2001; 11(2):207-8. PubMed ID: 11436964
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine augmentation in depressed patients with partial response to antidepressants.
    Olver JS; Ignatiadis S; Maruff P; Burrows GD; Norman TR
    Hum Psychopharmacol; 2008 Dec; 23(8):653-60. PubMed ID: 18816504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine augmentation for trichotillomania.
    Ashton AK
    Am J Psychiatry; 2001 Nov; 158(11):1929-30. PubMed ID: 11691706
    [No Abstract]   [Full Text] [Related]  

  • 34. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
    Matur Z; Uçok A
    Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder.
    de Geus F; Denys D; Westenberg HG
    Int Clin Psychopharmacol; 2007 Mar; 22(2):77-84. PubMed ID: 17293707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.
    Cutler AJ; Montgomery SA; Feifel D; Lazarus A; Aström M; Brecher M
    J Clin Psychiatry; 2009 Apr; 70(4):526-39. PubMed ID: 19358790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series.
    Pathak S; Johns ES; Kowatch RA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):696-702. PubMed ID: 16190801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of and therapy for Alzheimer-type dementia].
    Nakamura Y
    Seishin Shinkeigaku Zasshi; 2008; 110(7):577-84. PubMed ID: 18928020
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
    Wijkstra J; Burger H; van den Broek WW; Birkenhäger TK; Janzing JG; Boks MP; Bruijn JA; van der Loos ML; Breteler LM; Ramaekers GM; Verkes RJ; Nolen WA
    Acta Psychiatr Scand; 2010 Mar; 121(3):190-200. PubMed ID: 19694628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine augmentation of fluoxetine in body dysmorphic disorder.
    Phillips KA
    Am J Psychiatry; 2005 May; 162(5):1022-3. PubMed ID: 15863817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.